Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 13.89%156.81B | 14.24%42.11B | 7.84%40.15B | 17.10%38.11B | 17.36%36.45B | 18.76%137.69B | 20.88%36.86B | 36.25%37.24B | 13.69%32.55B | 5.29%31.05B |
Cost of revenue | 8.64%133.51B | 11.10%35.48B | 2.94%33.84B | 6.67%32.46B | 14.73%31.73B | 22.07%122.89B | 16.79%31.93B | 33.66%32.87B | 25.20%30.43B | 13.18%27.66B |
Gross profit | 57.47%23.3B | 34.55%6.62B | 44.67%6.32B | 167.50%5.65B | 38.75%4.72B | -3.04%14.8B | 56.43%4.92B | 59.42%4.37B | -51.11%2.11B | -32.81%3.4B |
Operating expense | 13.15%15.25B | 22.44%4.07B | 7.20%4B | 13.29%3.57B | 10.35%3.6B | 3.04%13.48B | -14.35%3.32B | 15.35%3.73B | 6.41%3.15B | 8.90%3.27B |
Operating profit | 509.61%8.05B | 59.72%2.55B | 266.40%2.31B | 299.14%2.08B | 736.09%1.11B | -39.46%1.32B | 317.85%1.6B | 226.45%631M | -176.90%-1.04B | -93.54%133M |
Net non-operating interest income (expenses) | -149.40%-626M | -362.16%-171M | -200.00%-156M | 28.27%-170M | 3.01%-129M | 20.57%-251M | 61.86%-37M | 355.74%156M | -169.32%-237M | -90.00%-133M |
Non-operating interest income | 4.23%148M | -46.77%33M | 80.00%54M | 42.86%40M | -4.55%21M | 158.18%142M | 264.71%62M | 172.73%30M | 1,300.00%28M | -12.00%22M |
Non-operating interest expense | 96.95%774M | 106.06%204M | 266.67%210M | -20.75%210M | -3.23%150M | 5.93%393M | -13.16%99M | -275.00%-126M | 194.44%265M | 63.16%155M |
Net investment income | -92.29%43M | 70.86%-95M | -97.41%6M | -99.65%1M | -64.59%131M | -7.31%558M | -208.31%-326M | 900.00%232M | 68.86%282M | 126.99%370M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | -87.71%200M | 0 | 10,753.33%1.63B | 3,397.37%1.25B | ||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | 48.51%-485M | 98.14%-7M | 107.55%21M | 45.63%-56M | -140.76%-443M | -259.12%-942M | -309.78%-377M | -6,850.00%-278M | -114.95%-103M | -18,300.00%-184M |
Less:Other special charges | -52.12%451M | -107.16%-27M | -107.55%-21M | -45.63%56M | 140.76%443M | 705.13%942M | 301.06%377M | 2,216.67%278M | 930.00%103M | 18,300.00%184M |
Less:Write off | --34M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Other non-operating income (expenses) | -106.57%-283M | -201.35%-223M | 111.87%33M | -117.26%-34M | -427.78%-59M | -217.09%-137M | -54.17%-74M | -480.82%-278M | 212.70%197M | -37.93%18M |
Income before tax | 216.94%6.9B | 1.03%2.06B | 188.54%2.42B | 301.44%1.82B | 200.99%611M | -31.75%2.18B | 388.26%2.04B | 260.84%838M | -141.22%-901M | -90.91%203M |
Income tax | -21.78%1.92B | -38.70%388M | -26.93%757M | -14.48%254M | 6.53%522M | 50.21%2.46B | 33.83%633M | 268.68%1.04B | 25.32%297M | -23.91%490M |
Net income | 1,892.09%4.98B | 18.85%1.67B | 930.50%1.66B | 230.41%1.56B | 131.01%89M | -117.87%-278M | 219.15%1.41B | 75.06%-200M | -161.42%-1.2B | -118.06%-287M |
Net income continuous operations | 1,892.09%4.98B | 18.93%1.67B | 938.89%1.66B | 230.30%1.56B | 131.01%89M | -117.87%-278M | 219.07%1.41B | 75.31%-198M | -161.47%-1.2B | -118.06%-287M |
Noncontrolling interests | 21.78%766M | 41.94%264M | 1.66%184M | 21.92%89M | 21.16%229M | 14.78%629M | 47.62%186M | 64.55%181M | -34.23%73M | -5.97%189M |
Net income attributable to the company | 564.83%4.22B | 15.25%1.41B | 487.66%1.48B | 215.91%1.47B | 70.80%-139M | -189.89%-907M | 193.49%1.22B | 58.22%-381M | -169.13%-1.27B | -134.27%-476M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 564.83%4.22B | 15.25%1.41B | 487.66%1.48B | 215.91%1.47B | 70.80%-139M | -189.89%-907M | 193.49%1.22B | 58.22%-381M | -169.13%-1.27B | -134.27%-476M |
Gross dividend payment | ||||||||||
Basic earnings per share | 567.44%117.42 | 16.19%39.25 | 490.06%41.19 | 216.12%40.84 | 70.69%-3.86 | -190.00%-25.12 | 193.47%33.78 | 58.16%-10.56 | -169.16%-35.17 | -134.26%-13.17 |
Diluted earnings per share | 567.44%117.42 | 16.19%39.25 | 487.80%40.9521 | 216.05%40.8135 | 70.69%-3.86 | -190.00%-25.12 | 193.47%33.78 | 58.17%-10.56 | -169.17%-35.17 | -134.26%-13.17 |
Dividend per share | 6.00%26.5 | 12.00%14 | 0 | 0.00%12.5 | 0 | 0.00%25 | 0.00%12.5 | 0 | 0.00%12.5 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |